July 29, 2026 · BMJ (Clinical research ed.) · DOI: 10.1136/bmj-2026-100163

Antihistamines for atopic dermatitis (eczema): systematic review and network meta-analysis of randomised trials

Listen to this summary

The authors aimed to systematically evaluate the benefits and harms of adding oral antihistamines for managing atopic dermatitis (eczema) through a network meta-analysis of randomized trials. They found that while antihistamines may slightly reduce atopic dermatitis and itch severity, these effects are clinically insignificant, and first-generation antihistamines are associated with increased cognitive impairment and treatment discontinuation. The study suggests that routine use of antihistamines in atopic dermatitis management is not supported by the evidence.

Alexandro W L Chu, Aaron Wen, Gordon H Guyatt, Muhammad Rao, Layla Bakaa, Irene X Zhao, Yetiani Roldan, Jonathan M Spergel, Jennifer LeBovidge, Mark Boguniewicz, Stephen A Martin, Mary Laura Lind, Jonathan I Silverberg, Peter A Lio, Rachel N Asiniwasis, Julie Wang, Anna De Benedetto, Matthew Greenhawt, Kathryn E Wheeler, Peck Y Ong, Winfred T Frazier, Harrison Nelson, Monica O'Brien, Korey Capozza, Wendy Smith Begolka, Donna D Gardner, Lynda C Schneider, Derek K Chu

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play